Reporting owner · CIK 0001995275
Lennon David James
Visual SEC Form 4 history across 2 companies, 9 transactions and 3 filings.
CEOCHIEF EXECUTIVE OFFICERWhitehawk Therapeutics, Inc.
Open-market mix
0%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Mar 25
−$13.4K
Apr 26
−$93.5K
Sep 26
$0
Transaction texture
Ownership and ticket size
Average P/S size$53.4K
Median P/S size$53.4K
Direct9
Indirect0
Sep 15, 2026grant
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
sale at Whitehawk Therapeutics, Inc. on Apr 02, 2026 valued at $93,466.
Review SEC filingLatest buy
No open-market insider purchase is available.
Associated companies
Visual map of known reporting history
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #225844 | WHWK | Lennon David James | CEO | grant | 193k | $0 | A | 09/18 | 09/15 |
| #225843 | WHWK | Lennon David James | CEO | grant | 193k | $0 | A | 09/18 | 09/15 |
| #220795 | WHWK | Lennon David James | CEO | grant | 831k | $0 | A | 04/03 | 04/01 |
| #220794 | WHWK | Lennon David James | CEO | exercise | 775k | $0 | M | 04/03 | 04/01 |
| #220793 | WHWK | Lennon David James | CEO | sale | 26.8k | -$9.34M | S | 04/03 | 04/02 |
| #220792 | WHWK | Lennon David James | CEO | exercise | 775k | — | M | 04/03 | 04/01 |
| #164156 | AADI | Lennon David James | CEO | exercise | 16.2k | $0 | M | 03/04/2025 | 03/01/2025 |
| #164155 | AADI | Lennon David James | CEO | sale | 5.69k | -$1.33M | S | 03/04/2025 | 03/03/2025 |
| #164154 | AADI | Lennon David James | CEO | exercise | 16.2k | — | M | 03/04/2025 | 03/01/2025 |
Lennon David James Insider Activity FAQ
SEC Form 4 context
Who is Lennon David James?
Lennon David James is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001995275.
Which companies has Lennon David James reported transactions for?
Whitehawk Therapeutics, Inc., Aadi Bioscience, Inc.
When was Lennon David James's latest insider buy?
No open-market insider purchase is available for this period.
When was Lennon David James's latest insider sale?
sale at Whitehawk Therapeutics, Inc. on Apr 02, 2026 valued at $93,466.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.